Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease
A new case report titled "Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report" has been published in Oncotarget.
Jan 24, 2024
0
0